Julia Smith

Communications at Alnylam

[Alnylam Pharmaceuticals @Alnylam]

We're honored AMVUTTRA (vutrisiran) has been nominated for the 2026 #PrixGalien USA Award for Best Biotechnology Product. Thank you to the patients, families, researchers, investigators & employees whose dedication helps advance the possibilities of #RNAi therapeutics. @GalienFdn

[Alnylam Pharmaceuticals @Alnylam]

We’re taking action to accelerate earlier detection and improve care coordination for patients with ATTR-CM through a collaboration with @Viz_ai and support for the @American_Heart.

Learn more: https://t.co/1lbt3Q0gF6

#ATTR #amyloidosis

[Pharmaceutical Market Europe @PMLiVEcom]

The winner of this year’s PMEA Company of the Year is … Alnylam. Congratulations! #PMEA25

[Alnylam Pharmaceuticals @Alnylam]

Now streaming: The world’s first album about primary #hyperoxaluria type 1 (PH1). United for Hyperoxaluria, we’ve dropped a YouTube playlist featuring a track with @OHFTweet, aiming to turn up awareness of PH1 this Hyperoxaluria Awareness Week. https://t.co/ZzAGbxTEh9

[Asian Media Awards @asianmediaaward]

The Asian Media Awards 2025 Winners List
https://t.co/ST1kc2OzTX

[Asian Media Awards @asianmediaaward]

Congratulations to @alnylam, @nkf_uk, and @sahealthaction on receiving the Creative Media Award for their outstanding 'No Stone Unturned: Kidney Health Campaign'. A powerful initiative that has raised vital awareness and made a meaningful impact in the field of kidney health.

[Asian Media Awards @asianmediaaward]

The full Asian Media Awards 2025 Finalists List https://t.co/Rgb2rL5L6v

[Alnylam Pharmaceuticals @Alnylam]

Ziggy’s parents knew something wasn’t right. Their persistence helped lead to his diagnosis of primary #hyperoxaluria type 1 (#PH1), a genetic #raredisease. For PH1 information and support, check out @OHFTweet. See how Jackie and Colin advocated for Ziggy: https://t.co/P5MWeSl4Rf

[Porphyria News @porphyria_news]

After years of mystery symptoms, Hannah found the answer in a diagnosis of AIP. Treatment, support, and dance helped her reclaim her life. https://t.co/P4wMbhcCdI

[MM+M @MMMnews]

‘Our bodies are art’: Alnylam campaign uses dance to tell patient’s story https://t.co/pdxefBXNhJ @Alnylam

[Alnylam Pharmaceuticals @Alnylam]

U.S. HCPs: Attending #PAS2025? Be sure to save the date for our symposium TOMORROW to learn more about the pediatric data available for our RNAi therapeutic for primary #hyperoxaluria type 1 (#PH1). @PASMeeting https://t.co/gPymeoiV2b

[Alnylam Pharmaceuticals @Alnylam]

HCPs: We’re thrilled to be headed to the PAS Annual Meeting 2025! Be sure to stop by Booth 1022 to meet with our Alnylam team and learn more about our work in primary #hyperoxaluria type 1 (#PH1). We hope to see you there!

#PAS2025 @PASMeeting

[Alnylam Pharmaceuticals @Alnylam]

Hannah’s first acute hepatic #porphyria (#AHP) attack left her feeling as though her mind and body were out of sync, and she could no longer do what she loved most: dance. Today, she’s back on stage, sharing her journey with AHP through dance.

[Alnylam Pharmaceuticals @Alnylam]

Managing a #RareDisease like primary #hyperoxaluria type 1 (PH1) can be difficult, so it’s helpful to work with patient advocacy groups to answer questions and get more information. Hear from Kim Hollander of @OHFTweet in an episode of Medical Stories. https://t.co/5pNI10dhDP

[Alnylam Pharmaceuticals @Alnylam]

For U.S. Audiences: Helping your loved one navigate primary #hyperoxaluria type 1 (PH1) can be a difficult journey. Learn about PH1 from pediatric nephrologist Dr. Stone as she discusses this #RareDisease and an FDA-approved treatment option.

[Alnylam Pharmaceuticals @Alnylam]

U.S. HCPs: Navigating a #RareDisease like PH1 requires a well-coordinated care team. In this article, pediatric nephrologist, Dr. Raymond Quigley, discusses how specialist collaboration can support timely diagnosis and highlights advances in disease management.

[Alnylam Pharmaceuticals @Alnylam]

We’re honored to receive the Swiss Tell Award, recognizing economic cooperation between 🇨🇭 and the 🇺🇸. Consul General Ambassador Niculin Jäeger presented the award to our CFO, Jeff Poulton, and members of our leadership team at a private dinner.

#TellAwards #SwissImpact

[Alnylam Pharmaceuticals @Alnylam]

For U.S. Audiences: Helping your loved one navigate primary #hyperoxaluria type 1 (PH1) can be a difficult journey. Learn about PH1 from pediatric nephrologist Dr. Stone as she discusses this #RareDisease and an FDA-approved treatment option.

[Alnylam Pharmaceuticals @Alnylam]

U.S. HCPs: Navigating a #RareDisease like PH1 requires a well-coordinated care team. In this article, pediatric nephrologist, Dr. Raymond Quigley, discusses how specialist collaboration can support timely diagnosis and highlights advances in disease management.

[Alnylam Pharmaceuticals @Alnylam]

For U.S. Audiences: Helping your loved one navigate primary #hyperoxaluria type 1 (PH1) can be a difficult journey. Learn about PH1 from pediatric nephrologist Dr. Stone as she discusses this #RareDisease and an FDA-approved treatment option.